Enphase Energy Reports Financial Results for the Fourth Quarter of 2025 FREMONT, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company, announced today financial results for the fourth quarter of 2025, which included the summary below from its President and CEO, Badri Kothandaraman. We reported quarterly revenue of $343.3 million in the fourth quarter of 2025, along with 46.1% for non-GAAP gross margin. We shipped approximately 1.55 million microinverters, or 682.6 megawatts DC, and 150.1 megawatt hours (MWh) of IQ® Batteries. Highlights for the f...
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences BOSTON and LONDON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences: Event: Guggenheim Emerging Outlook: Biotech SummitDate: Thursday, February 12, 2026Fireside Chat: 1:00 PM ET Event: TD Cowen 46th Annual Health Care ConferenceDate: Tuesday, March 3, 2026Fireside Chat: 3:10 PM ET Event: Leerin...
Enphase Energy Demonstrates Global IQ Bidirectional EV Charging Platform, Targeting Volume Production in Q4 2026 FREMONT, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company, today provided an update on the continued development of its IQ® Bidirectional EV Charging Platform, highlighting successful demonstrations, expanding global engagement, and ongoing validation across vehicles, homes, and grid environments in the United States and Europe. The DC-based IQ Bidirectional EV Charger is designed to connect to the direct current (DC) port of an ele...
Meridian Corporation Reports Fourth Quarter 2025 Results and Announces a Quarterly Dividend of $0.14 per Common Share MALVERN, Pa., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Meridian Corporation (Nasdaq: MRBK) today reported: Three Months Ended(Dollars in thousands, except per share data)(Unaudited)December 31,2025 September 30,2025 December 31,2024Income: Net income$7,186 $6,659 $5,601Diluted earnings per common share 0.61 0.58 0.49Pre-provision net revenue (PPNR)(1) 12,584 11,523 11,168(1) See Non-GAAP reconciliation in the Appendix Net income for the quarter ended December ...
Enphase Energy Highlights Firefighter Feedback on Microinverter-Based Solar Systems From SAFE Training Program FREMONT, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company, today shared feedback from firefighters who participated in training programs focused on modern solar system design and emergency response considerations. In post-training surveys, more than 98% of participating firefighters indicated they would recommend microinverter-based solar energy systems, based on their understanding of system design and safety characteristics. The sur...
Enphase Energy Announces Conference Call to Review Fourth Quarter and Full Year 2025 Financial Results Tuesday, Feb. 3, 2026 at 4:30 p.m. Eastern Time FREMONT, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- . (NASDAQ: ENPH), a global energy technology company, announced today that it will host a conference call and webcast on Tuesday, Feb. 3, 2026 at 4:30 p.m. Eastern Time to discuss its fourth quarter and full year 2025 financial results for the period ended Dec. 31, 2025. The live webcast can be accessed on the Enphase Energy Investor Relations website at , and a recorded version of the ca...
Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting Antidepressive effects and enhanced wakefulness were observed with OX2R activation in established animal model of major depressive disorder BOSTON and LONDON, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company focused on developing transformational medicines, today announced the presentation of new preclinical da...
Enphase Energy Begins Shipments of IQ9 Commercial Microinverters in the United States FREMONT, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company, today announced that it began production shipments of its IQ9N-3P™ Commercial Microinverter across the United States in late December 2025. The product is manufactured in the United States to support domestic content requirements and Foreign Entity of Concern (FEOC) compliance for eligible commercial solar projects. This is Enphase’s first microinverter powered by gallium nitride (GaN) technology and d...
Enphase Energy Expands Safe Harbor Agreement with a Leading TPO Provider FREMONT, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced a newly expanded safe harbor agreement with a leading solar financing company that offers third-party ownership (TPO) agreements to homeowners, including leases and power purchase agreements (PPAs). The newly expanded safe harbor agreement builds on a prior transaction with this leading TPO provider that was announced...
Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications Mario Alberto Accardi PhD, President and founder of Centessa’s Orexin Program, appointed Chief Executive Officer and member of the Board of Directors BOSTON and LONDON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that its Board of Directors has appointed Mario Alberto Accardi PhD, President and founder of Centessa’s Orexin Program, as Chief Executive O...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DALLAS, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on December 3, 2025, the Compensation Committee of Taysha's Board of Directors granted two new employees, in the aggregate, options to purchase 212,000 shares of the Company's common stock in connecti...
A director at Enphase Energy Inc sold 150,000 shares at 29.128USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Enphase Energy Begins Shipments of IQ EV Charger 2 in the United States FREMONT, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the first production shipments of its next-generation to customers across the United States. Designed in a sleek, modern black form factor, the IQ EV Charger 2 brings a premium aesthetic to home charging – pairing minimalist styling with rugged durability – and is designed to work seamlessly with Enphase solar and batt...
Enphase Energy Introduces PowerMatch Technology in Europe to Deliver More Usable Battery Energy and Savings FREMONT, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of PowerMatch™ technology in Europe. PowerMatch intelligently adjusts IQ® Battery output to match a home’s real-time power needs, delivering more usable energy, longer battery life, and greater long-term savings. Watch a about how it works. Unlike hybrid systems that pus...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.